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Remote interventions to improve exercise
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and beyond cancer: a systematic review
and meta-analysis
Saïd Ibeggazene1* , Rebecca Turner1, Derek Rosario2 and Liam Bourke1
Abstract
Background: The COVID-19 pandemic has forced many cancer services to consider a transition to a remote format
of delivery that is largely untested. Accordingly, we sought to perform a systematic review of the effects of
remotely delivered interventions to improve exercise behaviour in sedentary adults living with and beyond cancer.
Methods: Eligible studies were randomised controlled trials comparing a remotely delivered exercise intervention
to a usual care comparison in sedentary people over 18 years old with a primary cancer diagnosis. Nine electronic
databases were searched from inception to November 2020.
Results: The review included three trials, totalling 186 participants. Two of the included trials incorporated
prescriptions that meet current aerobic exercise recommendations, one of which also meets the guidelines for
resistance exercise. No trials reported an intervention adherence of 75% or more for a set prescription that meets
current exercise guidelines.
Conclusion: There is little evidence suggesting that remote exercise interventions promote exercise behaviours or
improve physical function in sedentary adults living with and beyond cancer. The development and evaluation of
novel remote exercise interventions is needed to establish their usefulness for clinical practice. Given the social
response to the COVID-19 pandemic, further research in this area is urgently needed.
Keywords: Cancer survivorship, Physical activity, Exercise behaviour, Telerehabilitation, Systematic review, Meta-
analysis
Background
Regular exercise can benefit the lives of people living
with and beyond cancer. Despite this, only 13–40% can-
cer survivors are physically active [1–4]. Supervised ra-
ther than unsupervised exercise is more effective at
promoting physical activity in previously inactive indi-
viduals [5], and recognised as an important component
of cancer care by healthcare organisations in several de-
veloped countries [6–8]. Widespread provision of super-
vised exercise services for cancer is not well established.
As of early 2020, delivery and introduction of many
direct face-to-face health services have been stymied by
the COVID-19 pandemic across the UK [9–11] and
other afflicted nations [12–15] which has caused many
providers to seek alternative modes of service delivery.
This is an appropriate initial response as the risks from
contracting COVID-19 to cancer populations are higher
than in the general population, principally due to
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advanced age and the presence of comorbidities [16]. Ex-
ercise facilities were associated with some early COVID-
19 clusters [17, 18]. In some countries exercise facilities
have reopened. Through the introduction of protective
measures and behavioural reactions to the COVID-19
pandemic, the risks associated with attending exercise
facilities may have reduced, however empirical data to
support this is lacking. If, and in what form, face-to-face
exercise programmes for cancer populations recom-
mence is at present uncertain. Considering this, inter-
ventions that deliver exercise interventions remotely,
such as in an individual’s home environment, may be-
come an essential tool for promoting exercise in people
with cancer.
Telemedicine is anticipated to play an increasing role in
healthcare [19, 20] and is being rapidly adopted by health-
care services [21], which may extend to clinical exercise
services for people with cancer in the future. The applica-
tion of remotely delivered exercise interventions may also
have the advantages of enhanced reach and accessibility
by overcoming known barriers to participation in face-to-
face supervised exercise. These physical and psychological
barriers include: poor or cold weather, lack of time [1, 22,
23], distance to travel to facility [24], negative perceptions
of programme and transport costs [25, 26], inconvenient
timings of exercise programmes [25, 27]. Furthermore,
cancer patients frequently state a preference to exercise in
their home environment and surrounding areas [23, 25,
27, 28] though this is not always the case [29].
Exercise interventions are often lauded to have sub-
stantial potential for cost savings to healthcare systems
[30], however, at present there is mixed evidence for the
cost-effectiveness of these in cancer populations [31, 32].
Remote delivery of exercise interventions could poten-
tially circumvent some of the costs of exercise services
related to upkeep of facilities and specialised equipment,
whilst offering a scalable service that caters to individ-
uals beyond a limited urban locale. Despite this promise,
the effectiveness of remotely delivered exercise interven-
tions in people with cancer is unclear. Previous system-
atic reviews of remote physical activity interventions in
cancer survivors have been unable to provide an answer
as to whether remotely delivered exercise interventions
are likely to be effective to promote exercise behaviours
or influence health outcomes [33, 34]. Potential reasons
for the ambiguous conclusions of these reviews include
methodological limitations of the included studies,
heterogenous intervention designs, inadequate control
conditions and inclusion of participants who are already
active at baseline. Therefore, the purpose of this review
is to assess the most recent evidence of the effects of re-
mote exercise interventions in people living with and be-




We performed this review using methods from previous
Cochrane systematic reviews by our group [5, 35]. In
addition, we supplemented this approach with criterion
to identify remotely delivered exercise intervention. Fur-
ther, due to early and evolving nature of the field, we in-
cluded studies with mixed cancer cohorts. Searches were
updated to November 2020.
Full text articles which had been included in the previ-
ous two reviews and those articles that were excluded
solely because they included a mixed cancer cohort were
screened for inclusion. The searches were run using the
same search strategy for the original review from incep-
tion to August 2012 [35] and the updated review from
August 2012 to May 2018 [5]. Full search strategies can
be found in the Supplementary materials. The subse-
quent searches from the following electronic databases
were run from May 2018 up to November 2020:
Cochrane Central Register of Controlled Trials, MEDL
INE, EMBASE, AMED, CINAHL, PsychINFO, Sport
DISCUS, Pubmed central and PEDro. We imported re-
sults from each database into a reference management
software package (Refworks, Proquest, Michigan, USA),
from which we removed duplicates.
Eligible studies
Randomised controlled trials (RCTs) that were aimed at
promoting aerobic and/or resistance exercise behaviours
in adults (> 18 years of age) who were physically inactive
or had a sedentary lifestyle at baseline (i.e. engaging in
less than 30 min of exercise of at least moderate inten-
sity, 3 days per week, or less than 90min in total of
moderate intensity exercise per week) were included.
Participants must have been diagnosed with cancer (his-
tologically or clinically) irrespective of sex, tumour type,
tumour site, tumour stage and type of anticancer treat-
ment received. Only studies that took place during or
after primary treatment or during active monitoring
were included.
Only interventions delivered remotely were included
(i.e. the intervention was delivered without face to face
contact or travel to a dedicated facility beyond the first
week of the intervention). Studies must include at least 6
weeks of follow-up. Studies must have reported the fre-
quency, duration and intensity of aerobic exercise behav-
iour or frequency, intensity, type, sets and repetitions of
resistance exercise behaviour that was prescribed in the
intervention. We excluded studies directed specifically at
end-of-life-care patients and individuals who were cur-
rently hospital inpatients. We did not include studies of
‘at risk’ populations (i.e. studies involving individuals
who have not been diagnosed with cancer) that ad-
dressed primary prevention research questions.
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Assessment of risk of bias in included studies
Risk of bias and methodological quality were assessed in
accordance with Cochrane’s tool for assessing risk of
bias [36]. We did not include judgements of the risk of
bias caused by blinding to group allocation, as it is not
possible (e.g. in a supervised exercise setting) to blind
participants to an intervention while promoting exercise
behaviour.
Two review authors (SI and LB) independently applied
the ‘Risk of bias’ tool, and differences were resolved by
discussion with a third review author (RT). We sum-
marised results in both a ‘Risk of bias’ graph (Fig. 3) and
a ‘Risk of bias’ summary (Fig. 2). We contacted study au-
thors to ask for additional information or for further
clarification of study methods if any doubt surrounded
potential sources of bias.
Outcomes
The primary outcomes were aerobic exercise behaviour
(frequency, duration, and intensity) and resistance exer-
cise behaviour (sets, repetitions, and intensity). Interven-
tions were judged as successfully achieving exercise
goals if investigators reported at least 75% adherence
over a given follow-up period [37] as per previous re-
views [5, 35].
We also assessed which interventions prescribed aer-
obic exercise of at least 150 min per week and with at
least 2 days per week of strength training, in line with
the American Cancer Society’s guidelines for exercise in
people living with and beyond cancer [6]. Our secondary
outcomes were change in aerobic fitness or exercise tol-
erance, change in skeletal muscle strength and endur-
ance, adverse events, study recruitment rate and
intervention attrition rate.
Screening and data extraction
Titles and abstracts were interrogated for eligibility by a
single reviewer (SI). Full text versions of potentially eli-
gible articles were then independently screened against
the inclusion criteria by two reviewers (SI and LB). Dis-
agreements between reviewers were resolved by discus-
sion with other members of the research team (RT). We
contacted study authors if we could not access a full
text, if we required more information to determine
whether a study could be included, or if we required
additional information about an already eligible study.
Data synthesis
We quantified data regarding adherence to the interven-
tion in terms of number of prescribed exercise sessions
completed as a proportion of the total prescription. The
‘Coventry, Aberdeen & London—Refined’ (CALO-RE)
taxonomy [38] was used to code behaviour-change tech-
niques (BCTs) within the interventions. Where
appropriate, meta-analyses of review outcomes were per-
formed. A fixed-effect model was used if there was no
significant statistical heterogeneity (I2 ≥ 50%). For con-
tinuous outcomes, the standardised mean difference be-
tween treatment arms was estimated by extracting the
final value and standard deviation of the outcome of
interest with the number of participants assessed at
follow-up. The Cochrane group RevMan version 5.3 (Re-
view Manager 2014) software was used to carry out
meta-analyses. If a meta-analysis was not possible or was
not appropriate, we narratively synthesised studies.
Results
We identified 4171 unique records from research data-
bases in addition to 12,325 records identified in previous
reviews. Seventy-two records were identified from title
and abstract screening from previous searches (see Fig. 1,
PRISMA flow chart). Including 50 records identified in
the updated search, 99 manuscripts were evaluated at
the full text stage.
After consensus agreement between study authors, 3
RCTs were included in this review [39–41]. A total of
186 participants were randomised in these trials. A total
of 4121 reports were excluded; reasons for exclusion
were: non RCTs – for example, reviews or comment/
editorial articles; cohorts that included non-cancer pop-
ulations; trials that were not remote trials that failed to
describe essential metrics of exercise prescription used
in the intervention; trials involving active participants at
baseline; trials involving hospital inpatients; interven-
tions that were < 6 weeks in follow-up; trials involving
participants < 18 years of age; not able to translate into
English.
Two trials [39, 41] included exclusively female breast
cancer survivors whilst Pinto et al. 2013 [40] included
both male and female survivors of colorectal cancer. All
trials included participants who had completed primary
or adjuvant therapy though one trial included partici-
pants who were receiving hormone-based therapy [41].
No studies included participants with metastatic disease.
Two trials included predominantly/overwhelmingly Cau-
casian (Pinto et al. 2005[39]- 95%; Pinto et al. 2013[40]-
97%) with one trial not reporting the ethnicity of partici-
pants. All trials took place in the North-eastern states of
the USA. Comorbidities at baseline were largely unclear
or unreported.
Two trials [39, 40] exclusively prescribed aerobic exer-
cise which could take the form of brisk walking, cycling,
swimming or using home exercise equipment though it
is unclear what activities were performed. One trial [41]
allocated individuals to perform aerobic exercise (walk-
ing), resistance exercise (resistance band exercises), both
or flexibility training (control). Two trials [39, 40] expli-
citly asked control participants not to modify their
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existing exercise behaviours. One trial [41] provided par-
ticipants with written guidance regarding how to exer-
cise at home. In all trials, contact was limited to weekly
phone calls, or weekly phone or email contacts [41],
after an initial one-to-one exercise consultation with re-
search staff. It was unclear whether healthcare profes-
sionals played a role in the interventions [39–41]. All
trials delivered their interventions over an initial 12-
week period. One trial [39] followed-up participants
again at 6- and 9-months post-randomisation and an-
other [40] followed-up participants at 6- and 12-months
post-randomisation, with both trials providing monthly
phone calls for 3 months after the initial 12-week inter-
vention period. In line with the recommendations of
Rock et al. [6]: one study [40] prescribed exercise that
complied with the recommendation to perform at least
150 min of aerobic exercise of per week and one study
[41] complied with the recommendation to prescribe re-
sistance exercise on at least 2 days per week.
All interventions were explicitly based on a theoretical
model. One intervention was based on the exercise and
self-esteem theory [41, 42], one on the transtheoretical
model alone [39, 43] and one combined the social
cognitive theory and transthoretical model [40, 43, 44].
It is unclear whether the prescription of flexibility exer-
cise to the control arm of the trial of Musanti [41] may
have influenced the self-esteem of the control group.
Details of the BCTs used in each of the included studies
are presented in Table 1. Full details of intervention be-
haviour change technique (BCT) coding according to
the CALO-RE taxonomy [38] can be found in the previ-
ous review [35].
All studies attempted to validate self-reported exer-
cise behaviour with pedometers [41] or uniaxial accel-
erometers [39, 40], however each study reported
conflicting results. Data regarding device-measured
physical activity were either not supportive of the
self-reported exercise behaviour data [39], were not
reported sufficiently to make a judgment [40] or their
use was discontinued during the study due to partici-
pants having difficulty using them [41]. One study
[41] also attempted to use heart rate monitoring via a
wearable sensor to objectively verify the exercise in-
tensities achieved by participants but the use of this
device was discontinued as participants reported find-
ing it difficult to use.
Fig. 1 PRISMA flow chart illustrating the study selection process
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Risk of bias in included studies
All studies included in the review were deemed to have
a high risk of bias. Full results of the risk of bias assess-
ment are illustrated in Figs. 2 and 3. One study used an
intention to treat analysis [39]. Two studies [39, 40] pro-
vided insufficient information to judge the risk related to
random sequence generation, allocation concealment or
blinding of outcome assessments. One study [41] was
judged as having a high risk of attrition bias as 24% (13/
54) of participants did not complete their assigned 12-
week programmes. Two studies were judged to have a
high risk of reporting bias with one [41] failing to report
waist and upper, mid and lower arm circumference out-
comes and another [40] not reporting accelerometer de-
rived physical activity data.
Other potential sources of bias of note include: miss-
ing adherence data for 50% of the participants [41], in
study dropouts significantly greater baseline levels of



















Fig. 2 Risk of bias summary: review authors’ judgements about each risk of bias item for each included study
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body fat, greater fatigue, greater muscular endurance,
lower levels of physical activity and a higher frequency
of allocation to resistance training were observed [41],
potential differences between cohorts at baseline [39],
inconsistencies between device objective/device-based
measures and subjective measures of physical activity/
exercise behaviour [39, 40].
Outcomes
No trials reported a 75% adherence to the Rock et al. [6]
guidelines for aerobic or resistance exercise
recommendations.
All studies included a measure of aerobic exercise tol-
erance which took the form of the Rockport 1-mile walk
test [39], a Treadwalk test [40] and a modified Bruce
protocol submaximal treadmill test. Aerobic exercise tol-
erance was unchanged in the intervention versus the
control at 12 weeks (SMD 0.70, 95% CI 0.37 to 1.03, 155
participants; very low-certainty evidence – Fig. 4). The
certainty of the evidence was graded as very low due to
high risk of bias, low number of participants within the
studies and wide confidence intervals.
One study reported changes in skeletal muscle
strength and endurance [41]. Skeletal muscle strength
was assessed as the six-repetition maximum using a
chest press, seated row and leg press and was signifi-
cantly increased at 12 weeks in those who performed re-
sistance training or aerobic and resistance training.
Skeletal muscle endurance was assessed using the curl-
up test and the YMCA bench press endurance test and
significantly increased in the resistance training, aerobic
and resistance training, and flexibility training but not
the aerobic training group. However, this study suffered
from a high risk of bias.
All studies reported adverse events. One study [40] re-
corded a cancer recurrence in the control arm. Another
study [39] reported a participant developing symptoms
of chest pain which they refused to have evaluated in the
intervention group. Finally [41], reported two cases of
recurrence of previous tendinitis: one in the shoulder
and the other in the foot; causing participants to tem-
porarily discontinue exercising and adopt lower exercise
intensities upon restarting.
Study recruitment rate ranged from 23% [41] to 70%
[39, 40]. Two studies used sample size estimates [40, 41]
Fig. 3 ‘Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as percentages across all included studies
Fig. 4 Meta-analysis of aerobic exercise tolerance at 8–12 weeks of follow-up. Note, in all meta-analysis data from Pinto et al. 2005 [39] has been
multiplied by − 1 to control for direction of effect (that is, lower values in a timed test indicate a better outcome). Data were extracted from the
combined aerobic and resistance training arm of [41]
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though neither were successful in achieving their recruit-
ment target. Two studies produced CONSORT diagrams
[39, 40]. Intervention attrition rates were reported by all
studies and ranged from 5% [39] and 7% [40] to 23%
[41].
Discussion
The findings of this review indicate that there is insuffi-
cient evidence to conclude that existing remote exercise
interventions are useful for achieving the Rock et al. [6]
guidelines of 150 min per week of aerobic exercise and
twice per week of resistance exercise, in sedentary adult
cancer cohorts. The scant availability of evidence was
apparent from the review process which highlights the
lack of research into the efficacy of remote exercise in-
terventions. Compared to another review which included
29 RCTs [34] we have only included 3 RCTs, owing to
stricter inclusion criteria which aimed to identify meth-
odological robust trials. The limited methodological
quality of published exercise studies in cancer popula-
tions has been noted previously [35]. Key issues that per-
sist are the reporting of exercise prescriptions in a way
that can be reproduced and failing to consider the activ-
ity status of representative cancer populations and the
influence of baseline activity status upon behavioural
and physiological outcomes as part of trial design. A
simple proposal to improve the reporting of interven-
tions in exercise oncology is for authors to use a re-
search checklist such as the “template for intervention
description and replication (TIDieR) checklist” [45] or
the “Consensus on exercise reporting template” [46].
Despite the lack of adherence to the exercise prescrip-
tions reported in the included trials, the interventions
appeared to cause improvements in aerobic exercise tol-
erance at 12 weeks of follow-up. This may have resulted
from the relatively large early gains in function expected
in sedentary participants from exercise training, which at
a group level could mask smaller changes in non-
adherers. Improvements in aerobic exercise tolerance
may not always be indicative of changes in aerobic fit-
ness caused by physiological adaptations to exercise
training and may partially reflect familiarization with
feelings of exertion during exercise testing and a better
tolerance towards perceptions of fatigue. Considering
this, alongside the very low quality of evidence for this
outcome and small sample size, we conclude that these
data are insufficient to support an effect on aerobic exer-
cise tolerance. Similarly, for the other secondary out-
comes assessed the limited amount and quality of
evidence for changes skeletal muscle strength and en-
durance, study recruitment rate and intervention attri-
tion rate preclude the drawing of definitive conclusions.
There was a high risk of bias for selective reporting, in-
complete outcome data and other trial-specific potential
biases such as contamination and baseline imbalances.
Despite this high risk of bias, the overall conclusions of
this review are unchanged.
There were few adverse events identified from the
studies included in this review. Two instances of tendon-
itis recurrence that occurred could potentially be attrib-
uted participation in an exercise intervention – though
this may result from a detection bias in the intervention
arm. The reported case of a cancer recurrence was not
unexpected. The definitions of adverse events were not
prespecified and as such it is unclear whether low-grade
adverse events (e.g. hot flushes, fatigue, nausea, joint
pain) which are typical in these populations were re-
corded. Information about low the prevalence of low-
grade adverse events would be useful in further elucidat-
ing the role of exercise in cancer care.
The recording and reporting of physical activity was
incomplete in the included studies which limits our un-
derstanding of the fidelity of their interventions. Self-
reported measures of physical activity could not be veri-
fied with device-based measures of activity for several
reasons including measurement error [47] and poor ad-
herence to wearing activity monitors such as accelerom-
eters or heart rate monitors. Heart rate monitors and
accelerometers can provide important data about inter-
vention fidelity and can potentially contribute to inter-
vention adherence by facilitating self-monitoring
behaviour. It is important to report barriers to the use of
such technologies and understand the effect that the use
of such devices may have on intervention outcomes to
guide future research.
A pertinent finding from this review is the lack of
high-quality trials with reproducible interventions inves-
tigating the efficacy of remote exercise interventions in
cancer populations. A possible reason for this is the rela-
tive infancy of cancer rehabilitation as a field compared
to better established clinical exercise services such as
cardiac rehabilitation [48]. Previous work in this area
has rightly focussed on establishing the efficacy of exer-
cise as a therapy which has typically been conducted in
highly controlled research settings with participants be-
ing closely supervised. The next steps for this field are to
establish how best to promote the exercise behaviours
that induce the desired physiological effect and resulting
clinical outcomes - the topic of two Cochrane systematic
reviews [5, 35].
Although all studies included in this review employed
BCTs and had a theoretical basis for the promotion of
exercise behaviours, no study achieved acceptable adher-
ence. In contrast, the use of BCTs was a common fea-
ture of exercise interventions with better adherence in
our previous review [5]. However, there are uncertainties
surrounding how well BCTs are implemented and re-
ported, how they interact with the context of a remote
Ibeggazene et al. BMC Cancer          (2021) 21:308 Page 8 of 10
intervention and with a how this mediates their effects
on health behaviours [49] which may explain this incon-
gruity. Trials in this review provided behavioural support
using weekly telephone calls, written information and/or
activity monitoring; there are many other emerging tech-
nologies (e.g. video calling) that can be utilised to pro-
vide behavioural support remotely, each of which
presents new contexts for the delivery of BCTs, which
must be understood and evaluated. Concerns about the
lack of engagement by the elderly with technology [50]
may have been stifled by the COVID-19 pandemic with
an increase in the proportion of people aged 65+ who
engage in weekly video calls from 23% in February 2020
to 61% in April/May 2020 [51]. Further research is
needed to understand which BCTs and how BCTs may
be used most effectively in remote exercise interventions
in sedentary cancer populations. This research can then
inform the design of adequately powered long term
RCTs and develop further understanding of whether
such interventions are effective in promoting exercise
behaviour in cancer survivors.
Limitations
Most of the limitations of the findings of this review are
due to the very small sample of studies and participants
that were identified – which itself is a principle finding.
Though this review aimed to address what was known
about remote exercise in a broad range of populations
the data available was limited to those who were largely
female, Caucasian and based in North Eastern America.
This narrow sample of research participants combined
with the imprecise estimates of treatment effects that re-
sult from the small total sample size leaves substantial
uncertainty about the transportability of the findings of
this review into other healthcare contexts. Clearly, there
is a need for further research in more diverse popula-
tions and healthcare settings may influence the partici-
pants engagement with and responses to interventions.
How the exercise prescriptions employed by the studies
in included in this review may have influenced any of
the outcomes measured is hard to determine due to the
limited adherence to the interventions and compromised
assessment of activity from wearable devices and self-
report measures.
Conclusion
At present, there is insufficient evidence to confirm
whether remote exercise interventions are useful in pro-
moting exercise behaviours and improving physical
function in sedentary adults living with and beyond can-
cer. This is largely due to a lack of studies addressing
this issue. The development and evaluation of novel re-
mote exercise interventions is needed to establish
whether these are useful tools for clinical practice.
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